人类病理性tau蛋白的分子特征区分与tau蛋白病相关的痴呆症
Molecular features of human pathological tau distinguish tauopathy-associated dementias
生物技术与制药领域的最新动态
Molecular features of human pathological tau distinguish tauopathy-associated dementias
Human orbitofrontal neural activity is linked to obsessive-compulsive behavioral dynamics
Sympathetic-epithelial crosstalk governs tissue-resident memory T cell immunosurveillance in the skin
Hallmarks of cancer—Then and now, and beyond
Chutes & Ladders—Cardiff churns C-suite to advance cancer candidate
Amgen jilts Kyowa, exiting $400M autoimmune pact after running vast pivotal program
Chugai drops only AI-assisted antibody from pipeline but still holds high hopes for tech
Moderna's latest CMO steps down after barely a year
Standard BioTools Completes Sale of SomaLogic to Illumina - citybiz
Standard BioTools Completes Sale of SomaLogic to Illumina - GlobeNewswire
Illumina bets $350M on proteins to help speed drug discovery - Stock Titan
Illumina completes acquisition of SomaLogic - PR Newswire
SomaLogic Partnership Resource Hub - Illumina
CDMOs dominate the headlines – and Lonza delivers a clear message of strength - European Biotechnology Magazine
Pharma’s outlook in 2026: Smoother sailing ahead?
How Big Pharma is navigating a $300 billion patent cliff
Humanwell Pharmaceutical patents new somatostatin SST4 receptor agonists for pain
Terns Pharmaceuticals patent discloses GIPR antagonists
Nimbus Salacia reports SIK2 inhibitors
Dual Bcl-xL/Bcl-2 degraders described in University of Florida patent